Ravi Joshi
President at PharmEng Technology, Inc.
Profile
Mr. Ravi Joshi is Chief Operating Officer at Keata Pharma, Inc. and President at PharmEng Technology, Inc. He is on the Board of Directors at FE (India) Ltd.
Mr. Joshi also served on the board at PharmEng International, Inc. and Novartis Pharmaceuticals Canada, Inc.
Ravi Joshi active positions
Companies | Position | Start |
---|---|---|
Keata Pharma, Inc. | Chief Operating Officer | - |
PharmEng Technology, Inc.
PharmEng Technology, Inc. Pharmaceuticals: MajorHealth Technology Part of PharmEng International, Inc., PharmEng Technology, Inc. is a full-service consulting firm that serves pharmaceutical, biotechnology, and medical device industries. The company is based in Toronto, Canada. PharmEng Technology prides itself on its proven track record of excellence which ensures that all client needs and governing regulatory expectations are met and exceeded. Since 1997, the Canadian company has provided industry-recognized services to assist clients in the rapid commercialization of new products from drug discovery to strategic planning to process scale up. The company was founded in 1977 by Alan Kwong. Alan Kwong has been the CEO since 1977. | President | - |
Former positions of Ravi Joshi
Companies | Position | End |
---|---|---|
PharmEng International, Inc.
PharmEng International, Inc. Miscellaneous Commercial ServicesCommercial Services PharmEng International, Inc. was a full-service consulting and contract manufacturing company, which serves the pharmaceutical and biotechnology industries. The company was founded on October 1, 2003 and was headquartered in Markham, ON. | Director/Board Member | 13/04/2009 |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
PharmEng International, Inc.
PharmEng International, Inc. Miscellaneous Commercial ServicesCommercial Services PharmEng International, Inc. was a full-service consulting and contract manufacturing company, which serves the pharmaceutical and biotechnology industries. The company was founded on October 1, 2003 and was headquartered in Markham, ON. | Commercial Services |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Health Technology |
Keata Pharma, Inc. | |
PharmEng Technology, Inc.
PharmEng Technology, Inc. Pharmaceuticals: MajorHealth Technology Part of PharmEng International, Inc., PharmEng Technology, Inc. is a full-service consulting firm that serves pharmaceutical, biotechnology, and medical device industries. The company is based in Toronto, Canada. PharmEng Technology prides itself on its proven track record of excellence which ensures that all client needs and governing regulatory expectations are met and exceeded. Since 1997, the Canadian company has provided industry-recognized services to assist clients in the rapid commercialization of new products from drug discovery to strategic planning to process scale up. The company was founded in 1977 by Alan Kwong. Alan Kwong has been the CEO since 1977. | Health Technology |
- Stock Market
- Insiders
- Ravi Joshi